Related Blog Posts
Vioxx Heart Risk Persists One Year After Stopping Use
5 hours ago ago from thesecrethealth.com
A new international study found that Merck's pain killer Vioxx (rofecoxib), which the drug company voluntarily withdrew from the market in 2004, found that a near two-fold increased risk of heart, stroke and death persisted for up to one year after stopping use. The study was the work of Dr Robert Bresalier, a professor of medicine at the MD Anderson Cancer Center in Houston, Texas, and colleagues from other research centres in the ...
Related contentRelated News
Nothing to see... move along.
Related Videos
Nothing to see... move along.
